Salihu (Oyiza) Asimawu: What If Blood Could Be Prepared in the Lab?
Salihu (Oyiza) Asimawu, Medical Laboratory Science Student and Research and Innovation Enthusiast at Ahmadu Bello University, shared a post on LinkedIn:
”What if blood could be prepared in the lab?
During my hematology lab posting at the cross-matching bench, I witnessed a situation that made me reflect deeply on innovation in healthcare. A patient required blood, but there was no exact match available in the blood bank. O-negative was in stock, yet the lab manager hesitated to release it immediately, as it is rare and may be urgently needed for another patient.
That moment sparked a discussion between a colleague and me: What if blood could be produced in the laboratory? What if bioengineered blood could reduce the constant pressure around scarce blood groups like O-negative?
We went on to ask a scientist about the possibility. He explained that while fully functional, clinically available lab-produced blood is not yet widely established, researchers have developed experimental red blood cells and oxygen-carrying substitutes that can mimic certain supplementary functions of blood.
Exploring further, I learned that although bioengineered blood vessels and some blood substitutes have been developed, fully functional lab-produced blood remains largely theoretical. Blood is not just red cells—it includes plasma, platelets, clotting factors, antibodies, and precise ABO/Rh antigens. Replicating all these components accurately makes it an incredibly complex scientific challenge.
This experience highlighted the vast potential for research and innovation in transfusion medicine and diagnostics. It strengthened my curiosity about contributing to solutions that could improve patient care and healthcare accessibility.”
Stay updated with Hemostasis Today.
-
May 29, 2026, 04:37Josefin Ahnström: How Andexanet Alfa Impacts TFPIα Function
-
May 29, 2026, 03:19Building Safer Systems for Anticoagulation Management – ISTH
-
May 29, 2026, 03:07Early Diagnosis Can Change the Lives of Women With Haemophilia – EHC
-
May 29, 2026, 02:41Ifeanyichukwu Ifechidere: The Biggest DOAC Myth in Coagulation – ‘No Monitoring Required’
-
May 29, 2026, 02:35Mariam Swidan: Why Is LDH the ‘Tattletale’ of the Lab?
-
May 29, 2026, 02:20Yuntian Wang: Multi-View Learning for Predicting Avatrombopag Response in Pediatric Immune Thrombocytopenia
-
May 29, 2026, 01:57Giuseppina Caligiuri: Pathophysiological Challenges and Emerging Therapeutic Strategies in Acute Stroke
-
May 28, 2026, 23:47Hussnain Javaid: The Importance of Targeted Examination in Iron Deficiency Anaemia
-
May 28, 2026, 23:47ASH Heads to ASCO26 with Career Opportunities and Global Hematology Leadership